COL4A1 and nonpapillary renal cell carcinoma: COL4A1 (type IV collagen α1) can be used as a prognostic biomarker in urothelial carcinoma [70], According to the results of the ceRNA network analysis of ccRCC by Zheng et al. [15], COL4A1 is related to the overall survival of patients.